|  |  |  | Tumor-related survival | Recurrence-free survival | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Name | Variables |  | Categorisation | Global | Stepwise reverse selection†| Global | Stepwise reverse selection†| ||||
 |  |  |  | p* | Hazard ratio | 95% Confidence interval | p | p* | Hazard ratio | 95% Confidence interval | p |
Model with dichotomous covariables | |||||||||||
T | Tumor stage | 0 | pT1-2 | 0.402 | Â | - | Â | 0.153 | Â | - | Â |
 |  | 1 | pT3-4 |  |  |  |  |  |  |  |  |
N | Lymp node status | 0 | pN0 | 0.002 | 5.050 | 2.264-11.267 | <0.001 | 0.038 | 2.934 | 1.303-6.607 | 0.009 |
 |  | 1 | pN1-3 |  |  |  |  |  |  |  |  |
G | Histologic grade | 0 | G1-2 | 0.136 | 1.875 | 0.946-3.715 | 0.072 | 0.007 | 3.188 | 1.442-7.052 | 0.004 |
 |  | 1 | G3 |  |  |  |  |  |  |  |  |
ER | Estrogen receptor status | 0 | negative | 0.168 | 0.420 | 0.213-0.829 | 0.012 | 0.047 | 0.357 | 0.173-0.733 | 0.005 |
 |  | 1 | positive |  |  |  |  |  |  |  |  |
HER2 | HER2 IHC | 0 | negative (0-1+) | 0.386 | Â | - | Â | 0.045 | 2.164 | 1.019-4.594 | 0.045 |
 |  | 1 | positive (2+-3+) |  |  |  |  |  |  |  |  |
CK5/6 | Cytokeratin 5/6 IHC | 0 | negative (0) | 0.085 | Â | - | Â | 0.305 | Â | - | Â |
 |  | 1 | positive (1+-3+) |  |  |  |  |  |  |  |  |
TP53 | TP53 IHC | 0 | <10% | 0.607 | Â | - | Â | 0.043 | 0.529 | 0.256-1.092 | 0.085 |
 |  | 1 | ≥ 10% |  |  |  |  |  |  |  |  |
YB1 | YB1 IHC | 0 | negative (0) | 0.530 | Â | - | Â | 0.738 | Â | - | Â |
 | 1 | positive (1+-3+) |  |  |  |  |  |  |  |  |  |